Aclaris Therapeutics
ACRS
$1.19
Share price
0.00%
Change (1 day)
-85.80%
Change (1 year)
Categories
P/S ratio for Aclaris Therapeutics (ACRS)
P/S ratio as of May 2024 (TTM): 2.71
According to Aclaris Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.71385. At the end of 2023 the company had a P/S ratio of 2.38.
P/S ratio history for Aclaris Therapeutics from 2015 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 2.38 | -93.26% |
| 2022 | 35.3 | -73.19% |
| 2021 | 132 | 192.45% |
| 2020 | 45.0 | 142.74% |
| 2019 | 18.5 | -41.64% |
| 2018 | 31.8 | -92.96% |
| 2017 | 452 | |
| 2016 | N/A | |
| 2015 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |